152 related articles for article (PubMed ID: 19000671)
1. The novel nicotinic receptor antagonist N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide decreases nicotine-induced dopamine metabolism in rat nucleus accumbens.
Rahman S; Neugebauer NM; Zhang Z; Crooks PA; Dwoskin LP; Bardo MT
Eur J Pharmacol; 2008 Dec; 601(1-3):103-5. PubMed ID: 19000671
[TBL] [Abstract][Full Text] [Related]
2. Region-specific effects of N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide on nicotine-induced increase in extracellular dopamine in vivo.
Rahman S; Zhang Z; Papke RL; Crooks PA; Dwoskin LP; Bardo MT
Br J Pharmacol; 2008 Feb; 153(4):792-804. PubMed ID: 18059317
[TBL] [Abstract][Full Text] [Related]
3. The novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB), inhibits nicotine-evoked [(3)H]norepinephrine overflow from rat hippocampal slices.
Smith AM; Dhawan GK; Zhang Z; Siripurapu KB; Crooks PA; Dwoskin LP
Biochem Pharmacol; 2009 Oct; 78(7):889-97. PubMed ID: 19631612
[TBL] [Abstract][Full Text] [Related]
4. The effects of a novel nicotinic receptor antagonist N,N-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB) on acute and repeated nicotine-induced increases in extracellular dopamine in rat nucleus accumbens.
Rahman S; Neugebauer NM; Zhang Z; Crooks PA; Dwoskin LP; Bardo MT
Neuropharmacology; 2007 Mar; 52(3):755-63. PubMed ID: 17097117
[TBL] [Abstract][Full Text] [Related]
5. N,N'-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivity.
Dwoskin LP; Wooters TE; Sumithran SP; Siripurapu KB; Joyce BM; Lockman PR; Manda VK; Ayers JT; Zhang Z; Deaciuc AG; McIntosh JM; Crooks PA; Bardo MT
J Pharmacol Exp Ther; 2008 Aug; 326(2):563-76. PubMed ID: 18460644
[TBL] [Abstract][Full Text] [Related]
6. Effect of a novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide, on nicotine self-administration and hyperactivity in rats.
Neugebauer NM; Zhang Z; Crooks PA; Dwoskin LP; Bardo MT
Psychopharmacology (Berl); 2006 Mar; 184(3-4):426-34. PubMed ID: 16220336
[TBL] [Abstract][Full Text] [Related]
7. bPiDI: a novel selective α6β2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse.
Wooters TE; Smith AM; Pivavarchyk M; Siripurapu KB; McIntosh JM; Zhang Z; Crooks PA; Bardo MT; Dwoskin LP
Br J Pharmacol; 2011 May; 163(2):346-57. PubMed ID: 21232049
[TBL] [Abstract][Full Text] [Related]
8. Repeated nicotine administration robustly increases bPiDDB inhibitory potency at alpha6beta2-containing nicotinic receptors mediating nicotine-evoked dopamine release.
Smith AM; Pivavarchyk M; Wooters TE; Zhang Z; Zheng G; McIntosh JM; Crooks PA; Bardo MT; Dwoskin LP
Biochem Pharmacol; 2010 Aug; 80(3):402-9. PubMed ID: 20346923
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a novel nicotinic receptor antagonist for the treatment of nicotine addiction: 1-(3-Picolinium)-12-triethylammonium-dodecane dibromide (TMPD).
Dwoskin LP; Joyce BM; Zheng G; Neugebauer NM; Manda VK; Lockman P; Papke RL; Bardo MT; Crooks PA
Biochem Pharmacol; 2007 Oct; 74(8):1271-82. PubMed ID: 17727820
[TBL] [Abstract][Full Text] [Related]
10. r-bPiDI, an α6β2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine Reinforcement.
Beckmann JS; Meyer AC; Pivavarchyk M; Horton DB; Zheng G; Smith AM; Wooters TE; McIntosh JM; Crooks PA; Bardo MT; Dwoskin LP
Neurochem Res; 2015 Oct; 40(10):2121-30. PubMed ID: 26227997
[TBL] [Abstract][Full Text] [Related]
11. Effects of repeated nicotine pre-treatment on mesoprefrontal dopaminergic and behavioral responses to acute footshock stress.
George TP; Verrico CD; Roth RH
Brain Res; 1998 Aug; 801(1-2):36-49. PubMed ID: 9729261
[TBL] [Abstract][Full Text] [Related]
12. The nicotinic receptor agonists (-)-nicotine and isoarecolone differ in their effects on dopamine release in the nucleus accumbens.
Mirza NR; Pei Q; Stolerman IP; Zetterström TS
Eur J Pharmacol; 1996 Jan; 295(2-3):207-10. PubMed ID: 8720585
[TBL] [Abstract][Full Text] [Related]
13. Blockade of NMDA receptors in the prefrontal cortex increases dopamine and acetylcholine release in the nucleus accumbens and motor activity.
Del Arco A; Segovia G; Mora F
Psychopharmacology (Berl); 2008 Dec; 201(3):325-38. PubMed ID: 18751970
[TBL] [Abstract][Full Text] [Related]
14. Nicotine-induced Fos expression in the nucleus accumbens and the medial prefrontal cortex of the rat: role of nicotinic and NMDA receptors in the ventral tegmental area.
Schilström B; De Villiers S; Malmerfelt A; Svensson TH; Nomikos GG
Synapse; 2000 Jun; 36(4):314-21. PubMed ID: 10819909
[TBL] [Abstract][Full Text] [Related]
15. Ethanol-induced dopamine elevation in the rat--modulatory effects by subchronic treatment with nicotinic drugs.
Löf E; Chau PP; Stomberg R; Söderpalm B
Eur J Pharmacol; 2007 Jan; 555(2-3):139-47. PubMed ID: 17141214
[TBL] [Abstract][Full Text] [Related]
16. Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.
Hildebrand BE; Nomikos GG; Hertel P; Schilström B; Svensson TH
Brain Res; 1998 Jan; 779(1-2):214-25. PubMed ID: 9473676
[TBL] [Abstract][Full Text] [Related]
17. Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain.
Liang Y; Boules M; Shaw AM; Williams K; Fredrickson P; Richelson E
Brain Res; 2008 Sep; 1231():6-15. PubMed ID: 18687313
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of the novel nicotinic receptor antagonist N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide in the rat.
Albayati ZA; Dwoskin LP; Crooks PA
Drug Metab Dispos; 2008 Oct; 36(10):2024-9. PubMed ID: 18617603
[TBL] [Abstract][Full Text] [Related]
19. Long-term nicotine treatment down-regulates α6β2* nicotinic receptor expression and function in nucleus accumbens.
Perez XA; McIntosh JM; Quik M
J Neurochem; 2013 Dec; 127(6):762-71. PubMed ID: 23992036
[TBL] [Abstract][Full Text] [Related]
20. Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats.
Carboni E; Bortone L; Giua C; Di Chiara G
Drug Alcohol Depend; 2000 Feb; 58(1-2):93-102. PubMed ID: 10669059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
